While B-ALL is the most common childhood cancer and one of the most treatable, some patients face grim outcomes after they ...

Some of what RFK Jr. says about obesity prevention isn't new. But after having coined the catchy MAHA acronym, it’s likely ...

Four oral glucagon-like peptide-1 receptor (GLP1R) drugs, currently under Phase III trials, are in the race for approval, acc ...

The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular ...

For employers wanting to dip a toe into the GLP-1 medications pool, utilization management is recommended to control costs.

A new study finds people who take weight-loss drugs also cut back on alcohol consumption. Researchers think the drugs could ...

GLP-1 agonist medications such as Ozempic accounted for 10% of the North Carolina state employee health plan’s prescription ...

The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity ...

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce alcohol consumption and improve outcomes in some ...

The impact of GLP-1 RAs on alcohol use is explored, showing potential benefits in reducing intake and cravings, but with ...